Achilles Therapeutics (ACHL) News Today $0.83 -0.01 (-1.19%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 27 at 1:42 AM | americanbankingnews.comCritical Contrast: Achilles Therapeutics (NASDAQ:ACHL) versus X4 Pharmaceuticals (NASDAQ:XFOR)May 22, 2024 | globenewswire.comAchilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer VaccinesMay 17, 2024 | globenewswire.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementMay 8, 2024 | investorplace.comACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024May 8, 2024 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | globenewswire.comAchilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsApril 17, 2024 | msn.comAchilles Therapeutics plc - Depositary Receipt () (ACHL) Price Target Decreased by 56.41% to 2.89April 5, 2024 | msn.comPiper downgrades Achilles to neutral, cites latest dataApril 4, 2024 | markets.businessinsider.comACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023April 4, 2024 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host ConditioningApril 1, 2024 | marketbeat.comAchilles Therapeutics (ACHL) to Release Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, April 2, Yahoo Finance reports.March 7, 2024 | finance.yahoo.comWill Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?March 4, 2024 | marketbeat.comAchilles Therapeutics (ACHL) Set to Announce Quarterly Earnings on TuesdayAchilles Therapeutics (NASDAQ:ACHL) will be releasing earnings on Tuesday, March 5, Yahoo Finance reports.February 22, 2024 | wsj.comAchilles Therapeutics PLC ADRFebruary 22, 2024 | benzinga.comAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest ReportFebruary 9, 2024 | investing.comAchilles Therapeutics PLC ADR (ACHL)February 5, 2024 | finance.yahoo.comAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceDecember 22, 2023 | benzinga.comAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and DatesDecember 20, 2023 | seekingalpha.comACHL Achilles Therapeutics plcDecember 18, 2023 | finance.yahoo.comAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity PredictionNovember 22, 2023 | foxnews.comSteelers lose Kwon Alexander for season with torn Achilles: reportsNovember 14, 2023 | msn.comAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02October 29, 2023 | foxnews.comAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recoverySeptember 23, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementSeptember 22, 2023 | uk.style.yahoo.comAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?September 21, 2023 | usatoday.comAaron Rodgers says he's starting 'road to recovery' after Achilles surgery went 'great'September 17, 2023 | usatoday.comJets QB Aaron Rodgers to miss rest of NFL season with torn AchillesSeptember 14, 2023 | dailymail.co.ukAaron Rodgers said he was 'manifesting' a Super Bowl run for the Jets in interview with John McEnroe that aired just MINUTES before he suffered season-ending Achilles injurySeptember 14, 2023 | cbsnews.comAaron Rodgers' Achilles injury is "not good," Jets head coach says, as star quarterback is set to get MRISeptember 6, 2023 | finance.yahoo.comIs KalVista Pharmaceuticals (KALV) Stock Outpacing Its Medical Peers This Year?August 7, 2023 | msn.comChardan Capital Reiterates Achilles Therapeutics Plc - ADR (ACHL) Buy RecommendationAugust 4, 2023 | finance.yahoo.comAchilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business HighlightsJune 12, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics to Present at Upcoming ConferencesMay 11, 2023 | msn.comAchilles Therapeutics: Q1 Earnings InsightsMay 10, 2023 | seekingalpha.comAchilles Therapeutics GAAP EPS of -$0.44May 10, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business HighlightsMay 10, 2023 | finance.yahoo.comAchilles Therapeutics’ New Immunogenicity Prediction Application of its AI-Powered PELEUS™ Platform Uniquely Identifies the Most Potent T Cell AntigensMay 10, 2023 | finance.yahoo.comAchilles Therapeutics Reports First Quarter 2023 Financial Results and Recent Business HighlightsApril 25, 2023 | finance.yahoo.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementApril 25, 2023 | finance.yahoo.comAchilles Therapeutics Announces Grant of US Patent Covering the Treatment of Patients with an Immunotherapy Targeting Neoantigens Based on Tumor HLA StatusApril 17, 2023 | finance.yahoo.comAchilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing SummitMarch 24, 2023 | health.usnews.comGerard Achilles M. ObnialMarch 24, 2023 | dailymail.co.ukMe and my operation: achilles tendon surgeryMarch 7, 2023 | finanznachrichten.deAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business HighlightsMarch 7, 2023 | finance.yahoo.comAchilles Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Business HighlightsJanuary 17, 2023 | finance.yahoo.comIs Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year?December 20, 2022 | finance.yahoo.comAchilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare ConferenceDecember 6, 2022 | finance.yahoo.comAchilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022 Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Collapse of the Petrodollar (Ad)The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. In answer to this issue, we have released a Special Report to the public. ACHL Media Mentions By Week ACHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHL News Sentiment▼1.440.62▲Average Medical News Sentiment ACHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHL Articles This Week▼30▲ACHL Articles Average Week Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BLUE News ATHA News TVGN News OPT News VXRT News CLLS News CRDF News OMGA News ELUT News HLVX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.